Tag Archives: Fast

Amgen's AMG420 shows responses in myeloma trial, gets FDA fast track

SAN DIEGO (Reuters) – Amgen Inc, updating the first trial of its bispecific antibody for multiple myeloma, on Monday said seven out of ten patients given the second-highest dose of AMG420 responded to the drug, including four with no detectable cancer. FILE PHOTO – An Amgen sign is seen at the company’s office in South… Read More »